ZHONGSHENGYAOYE(SZ:002317) Zheng Quan Zhi Xing·2025-08-15 16:24Core Viewpoint - Guangdong Zhongsheng Pharmaceutical Co., Ltd. has approved a guarantee of up to RMB 2 billion for its subsidiaries to support their operational activities and improve capital efficiency [1][2]. Group 1: Guarantee Overview - The company has authorized the chairman to implement the guarantee based on specific circumstances, allowing for a total guarantee of RMB 2 billion for its subsidiaries [1]. - The company has signed maximum guarantee contracts with various banks for its subsidiaries, including RMB 100 million for Guangdong South China Pharmaceutical Group Co., Ltd. and RMB 20 million for Yunnan Yikang Pharmaceutical Co., Ltd. [2][10]. Group 2: Financial Data of Subsidiaries - Guangdong South China Pharmaceutical Group Co., Ltd. reported total assets of RMB 110,867.85 million and a net profit of RMB 1,016.79 million for the first quarter of 2025 [5]. - Guangdong Zhongsheng Medical Trading Co., Ltd. had total assets of RMB 150,681.25 million and a net profit of RMB 282.36 million for the first quarter of 2025 [6]. - Yunnan Yikang Pharmaceutical Co., Ltd. reported total assets of RMB 25,563.19 million and a net profit of RMB 200.23 million for the first quarter of 2025 [8]. - Yunnan Zhongkang Traditional Chinese Medicine Planting Co., Ltd. had total assets of RMB 3,154.40 million and a net profit of -56.00 million for the first quarter of 2025 [9]. Group 3: Guarantee Amounts and Ratios - The total guarantee amount provided by the company is RMB 124,600 million, which accounts for 31.83% of the company's audited net assets as of December 31, 2024 [11]. - The guarantees for subsidiaries include RMB 40,000 million for Guangdong South China Pharmaceutical, RMB 80,000 million for Guangdong Zhongsheng Medical Trading, RMB 4,000 million for Yunnan Yikang Pharmaceutical, and RMB 600 million for Yunnan Zhongkang Traditional Chinese Medicine [12].